Yes, we perform formulation development for Phase I, Phase IIa, Phase II, and first-in-human clinical trials. Development is performed in small scale to increase speed and decrease cost with the focus of developing an effective formulation that is stable through the length of the clinical trial. As an R&D-focused CDMO, we are able to manufacture small prototype formulation batches that save money and can be manufactured quickly. Typically, we can develop first-in human clinical trial formulations and manufacture cGMP clinical batches in a matter of months.
Our team is connected to a network of certified and approved sourcing vendors around the globe. As experts in analytical method development, testing, and FDA regulatory filings, our team brings this expertise when selecting both active and inactive ingredients to ensure that the formulations we develop comply with all necessary FDA requirements.